ITI Pharma and Healthcare Fund Regular vs Nippon India Pharma Fund compare
ITI Pharma and Healthcare Fund Regular - Growth
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Fund | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹166 Cr | ₹7404 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹500 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 08 Nov 2021 | 01 Jun 2004 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open-ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
| Turn Over | % | 21% |
| Expense Ratio | 2.34 | 1.82 |
| Manager | Rohan Korde | Sailesh Raj Bhan |
| ISIN Code | INF00XX01BL5 | INF204K01968 |
| Exits Load | Exit load of 1% if redeemed within 12 months./365 | Exit load of 1% if redeemed within 1 month./365 |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Month | -2.79% | -4.24% |
| 6 Month | 21.52% | 15.32% |
| 1 Year | 43.77% | 35.43% |
| 3 Year | 18.29% | 18.33% |
| 5 Year | - | 26.98% |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 40.97% | 31.44% |
| 3 Year | - | 30.78% |
| 5 Year | - | 25.57% |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Year | 20.74% | 17.79% |
| 3 Year | 19.19% | 20.87% |
| 5 Year | - | 20.18% |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Standard Deviation | 14.52% | 14.36% |
| Sharp | - | 0.68% |
| Beta | - | 0.91% |
| Alpha | - | 1.57% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Name | Rohan Korde | Sailesh Raj Bhan |
| Total AUM | ₹4626 Cr | ₹96086 Cr |
| Fund Manage | 10 | 5 |
| ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 0.48 | 4.4 |
| Mid Cap | 28.05 | 27.12 |
| Small Cap | 32.19 | 22.52 |
| Large Cap | 39.28 | 45.96 |
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 0.48 | 4.4 |
| Healthcare | 96.77 | - |
| Chemicals | 2.75 | - |
| Pharmaceuticals & Biotechnology | - | 75.86 |
| Healthcare Services | - | 17.38 |
| Retailing | - | 2.36 |
Top Comparisons
Motilal Oswal ELSS Tax Saver Fund (MOFLTE) - Regular Plan - Growth Option
3Y Returns23.17%
Quant ELSS Tax Saver Fund Regular Plan-Growth
3Y Returns16.17%
HSBC Liquid Fund - Regular Growth
3Y Returns6.25%
Canara Robeco Liquid Fund - Regular Plan - Growth Option
3Y Returns6.27%
Invesco India - Invesco Pan European Equity Fund of Fund - Regular Plan - Growth Option
3Y Returns5.12%
Tata Silver ETF Fund of Fund - Regular (G)
3Y Returns0%
LIC MF Bond Fund-Regular Plan-Growth
3Y Returns5.84%
UTI Medium to Long Duration Fund- Regular Plan - Growth
3Y Returns7.88%